Viewing Study NCT03776058


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-04 @ 9:33 PM
Study NCT ID: NCT03776058
Status: COMPLETED
Last Update Posted: 2018-12-14
First Post: 2018-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module